Surgery for GEP-NETs

Best Practice and Research: Clinical Gastroenterology

Volumn 26, Issue 6, 2012, Pages 819-831

  Knigge, Ulrich ^a   Hansen, Carsten Palnæs ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Appendix NET; Chemoembolization; Colo rectal NET; Duodenal NET; Embolization; Gastric NET; Gastrinomas; Insulinomas; MEN 1; Neuroendocrine carcinomas; Neuroendocrine tumours; Pancreatic NET; Radioembolization; Radiofrequency ablation; Small intestinal NET; Surgery

Indexed keywords

APPENDICEAL NEUROENDOCRINE NEOPLASM; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURGERY; CONSERVATIVE TREATMENT; CYTOREDUCTIVE SURGERY; DISTANT METASTASIS; ENDOSCOPIC MUCOSAL RESECTION; FOLLOW UP; GASTRINOMA; GASTROSTOMY; GOBLET CELL CARCINOID; HEMICOLECTOMY; HUMAN; INSULINOMA; INTESTINE RESECTION; LAPAROSCOPIC SURGERY; LIVER METASTASIS; LIVER TRANSPLANTATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MESENTERY LYMPH NODE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; NON FUNCTIONING NEOPLASM; PANCREAS TUMOR; PANCREATIC NEUROENDOCRINE TUMOR; PANCREATICODUODENECTOMY; SALPINGOOOPHORECTOMY; SIGMOIDECTOMY; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOID; TOTAL STOMACH RESECTION;

EID: 84876122612     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2012.12.005     Document Type: Review

References (69)

1. R. Salazar, B. Wiedenmann, G. Rindi, P. Ruszniewski, and (guest editors) ENETS 2011 consensus guideline for the management of patients with neuroendocrine tumors Neuroendocrinology 95 2012 69 176
2. L.K. Kvols, and K.L. Brendtro The North American Neuroendocrine Tumor Society (NANETS) guidelines: mission, goals, and process Pancreas 39 2010 705 706
3. E. Tiensuu Janson, H. Sorbye, S. Welin, B. Federspiel, H. Grønbæk, and P. Hellman Nordic guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours Acta Oncol 49 2010 740 756
4. H. Scherübl, G. Cadiot, R.T. Jensen, T. Rösch, U. Stölzel, and G. Klöppel Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy 42 2010 664 671
5. G. Delle Fave, D.J. Kwekkeboom, E. Van Cutsem, G. Rindi, B. Kos-Kudla, and U. Knigge ENETS consensus guidelines for the management of patients with gastroduodenal neoplasms Neuroendocrinology 95 2012 74 87
6. K. Borch, B. Ahrén, H. Ahlman, S. Falkmer, G. Granérus, and L. Grimelius Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type Ann Surg 242 2005 64 73
7. V. Fendrich, and D.K. Bartsch Surgical treatment of gastrointestinal neuroendocrine tumors Langenbecks Arch Surg 396 2011 299 311
8. R.T. Jensen, G. Rindi, R. Arnold, J.M. Lopes, M.L. Brandi, and W.O. Bechstein Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas) Neuroendocrinology 84 2006 165 172
9. J.T. Mullen, H. Wang, J.C. Yao, J.H. Lee, N.D. Perrier, and P.W. Pisters Carcinoid tumors of the duodenum Surgery 138 2005 971 977
10. P. Hellman, M. Andersson, J. Rastad, C. Juhlin, S. Karacagil, and B. Eriksson Surgical strategy for large or malignant endocrine pancreatic tumors World J Surg 24 2000 1353 1360
11. J.A. Norton, M. Kivlen, M. Li, D. Schneider, T. Chuter, and R.T. Jensen Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors Arch Surg 138 2003 859 866
12. T. Hackert, U. Hinz, S. Fritz, O. Strobel, L. Schneider, and W. Hartwig Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections Langenbecks Arch Surg 396 2011 1197 1203
13. C. Brient, N. Regenet, L. Sulpice, L. Brunaud, S. Mucci-Hennekine, and N. Carrère Risk factors for pancreatic fistulization subsequent to enucleation J Gastrointest Surg 16 2012 1883 1887
14. J.A. Norton Intraoperative methods to stage and localize and stage pancreatic and duodenal tumors Ann Oncol 10 Suppl. 4 1999 182 184
15. V. Fendrich, P. Langer, and I. Celik An aggressive surgical approach leads to long-term survival in patients with endocrine tumors Ann Surg 244 2006 845 851
16. H. Chen, J.M. Hardacre, A. Uzar, J.L. Cameron, and M.A. Choti Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 187 1998 88 92 [discussion 92-93]
17. R.S. Chamberlain, D. Canes, K.T. Brown, L. Saltz, W. Jarnagin, and Y. Fong Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 190 2000 432 445
18. M.G. House, J.L. Cameron, K.D. Lillemoe, R.D. Schulick, M.A. Choti, and D.E. Hansel Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer J Gastrointest Surg 10 2006 138 145
19. R. Arnold, Y.J. Chen, F. Costa, M. Falconi, D. Gross, and A.B. Grossman ENETS concensus guidelines for the standards of care in neuroendocrine tumors: follow- up and documentation Neuroendocrinology 90 2009 227 233
20. L. Fernandez-Cruz, L. Blanco, R. Cosa, and H. Rendòn Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors? World J Surg 32 2008 904 917
21. D.B. Evans, J.M. Skibber, J.E. Lee, K.R. Cleary, J.A. Ajani, and R.F. Gagel Nonfunctioning islet cell carcinoma of the pancreas Surgery 114 1993 1175 1181
22. C.C. Solorzano, J.E. Lee, P.W. Pisters, J.N. Vauthey, G.D. Ayers, and M.E. Lean Nonfunctioning islet cell carcinoma of the pancreas: survival and results in a contemporary series of 163 patients Surgery 130 2001 1078 1085
23. L. Fischer, J. Kleeff, I. Esposito, U. Hinz, A. Zimmermann, and H. Friess Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumors of the pancreas Br J Surg 95 2008 627 635
24. K. Vanderveen, and C. Grant Insulinoma Cancer Treat Res 153 2010 235 252
25. J.M. Guettier, and P. Gorden Insulin secretion and insulin-producing tumors Expert Rev Endocrinol Metab 5 2010 217 227
26. Y.P. Zhao, H.X. Zhan, T.P. Zhang, L. Cong, M.H. Dai, and Q. Liao Surgical management of patients with insulinomas: result of 292 cases in a single institution J Surg Oncol 103 2011 169 174
27. A. Isla, J.D. Arbuckle, P.B. Kekis, A. Lim, J.E. Jackson, and J.F. Todd Laparoscopic management of insulinomas Br J Surg 96 2009 185 190
28. M.L. Richards, G.B. Thompson, D.R. Farley, M.L. Kendrick, J.F. Service, and A. Vella Setting the bar for laparoscopic resection of sporadic insulinoma World J Surg 35 2011 785 789
29. A. Raffel, M.M. Krausch, M. Anlauf, D. Wieben, S. Braunstein, and G. Klöppel Diffuse nesidioblastosis as a cause of hypoinsulinemic hypoglycemia in adults: a diagnostic and therapeuthic challenge Surgery 141 2007 179 184
30. R.T. Jensen, B. Niederle, E. Mirty, J.K. Ramage, T. Steinmüller, and Lewington Gastrinoma (duodenal and pancreatic) Neuroendocrinology 84 2006 173 182
31. E.H. Morrow, and J.A. Norton Surgical management of Zollinger-Ellison syndrome; state of the art Surg Clin North Am 89 2009 1091 1103
32. J.A. Norton, D.L. Fraker, H.R. Alexander, F. Gibril, D.J. Liewehr, and D.J. Venzon Surgery increases survival in patients with gastrinoma Ann Surg 244 2006 410 419
33. V.A. Fishbeyn, J.A. Norton, R.V. Benya, J.R. Pisegna, D.J. Venzon, and D.C. Metz Assessment and prediction of long-term cure in patients with Zollinger-Ellison syndrome: the best approach Ann Intern Med 119 1993 199 206
34. F. Gibril, and R.T. Jensen Advances in evaluation and management of gastrinoma in Zollinger-Ellison syndrome Curr Gastroenterol Rep 7 2005 114 121
35. D. O'Toole, R. Salazar, M. Falconi, G. Kaltsas, A. Couvelard, and W.W. de Herder Rare functioning pancreatic endocrine tumors Neuroendocrinology 84 2006 196 211
36. F. Gibril, D.J. Venzon, J.V. Ojeaburu, S. Bashir, and R.T. Jensen Prospective study of the natural history of gastrinoma in patients with MEN-1: definition of an aggressive and nonaggressive form J Clin Endocrinol Metab 86 2001 5282 5293
37. J.A. Norton, H.R. Alexander, D.I. Fraker, D.J. Venzon, F. Gibril, and R.T. Jensen Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome Ann Surg 234 2001 495 506
38. J.A. Norton, T.D. Fang, and R.T. Jensen Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1 J Natl Compr Canc Netw 4 2006 148 153
39. R.T. Jensen, G. Cadiot, M.L. Brandi, W.W. de Herder, G. Kaltsas, and P. Komminoth ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes Neuroendocrinology 95 2012 98 119
40. P. Hellman, T. Lundström, U. Ohrvall, B. Eriksson, B. Skogseid, and K. Oberg Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases World J Surg 26 2002 991 997
41. A. Ahmed, G. Turner, B. King, L. Jones, D. Culliford, and D. McCance Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study Endocr Relat Cancer 16 2009 885 894
42. U.F. Pape, A. Perren, B. Niederle, D. Gross, T. Gress, and F. Costa ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas Neuroendocrinology 95 2012 135 156
43. R. Sutton, H.E. Doran, E.M. Williams, J. Vora, S. Vinjamuri, and J. Evans Surgery for midgut carcinoid Endocr Relat Cancer 10 2003 469 481
44. B. Givi, S.J. Pommier, A.K. Thompson, B.S. Diggs, and R.F. Pommier Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival Surgery 140 2006 891 897
45. J. Strosberg, N. Gardner, and L. Kvols Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the mid-gut Neuroendocrinology 89 2009 471 476
46. U. Plöckinger, A. Couvelard, M. Falconi, A. Sundin, R. Salazar, and E. Christ Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma Neuroendocrinology 87 2008 20 30
47. B. Stinner, and M. Rothmund Neuroendocrine tumours (carcinoids) of the appendix Best Pract Res Clin Gastroenterol 19 2005 729 738
48. T.H. Pham, B. Wolff, S.C. Abraham, and E. Drelichman Surgical and chemotherapy treatment outcomes of goblet cell carcinoid: a tertiary cancer center experience Ann Surg Oncol 13 2006 370 376
49. L.H. Tang, J. Shia, R.A. Soslow, D. Dhall, W.D. Wong, and E. O'Reilly Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix Am J Surg Pathol 32 2008 1429 1443
50. M. Caplin, A. Sundin, O. Nilsson, R.P. Baum, K.J. Klose, and F. Kelestimur ENETS concensus guidelines for the management of patients with neuroendocrine neoplasms: colorectal neuroendocrine neoplasms Neuroendocrinology 95 2012 88 97
51. M.R. Kwaan, J.E. Goldberg, and R. Bleday Rectal carcinoid tumors: review of results after endoscopic and surgical therapy Arch Surg 143 2008 471 475
52. Y. Onozato, S. Kakizaki, H. Lizuka, M. Mori, and H. Itoh Endoscopic treatment of rectal carcinoid tumors Dis Colon Rectum 53 2010 169 176
53. T. Kinoshita, E. Kaneheira, K. Omura, T. Tomori, and H. Yamada Transanal endoscopic microsurgery in the treatment of rectal carcinoid tumor Surg Endosc 21 2007 970 974
54. A.Y. Wang, and N.A. Ahmad Rectal carcinoids Curr Opin Gastroenterol 22 2006 529 535
55. I.H. Olsen, S.W. Langer, I. Jepsen, M. Assens, B. Federspiel, and J.P. Hasselby First-line treatment of patients with sisseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience Acta Oncol 51 2012 97 100
56. H. Sorbye, S. Welin, S.W. Langer, L.W. Vestermark, N. Holt, and P. Osterlund Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study Ann Oncol 24 2012 152 160
57. U. Knigge, C.P. Hansen, and F. Stadil Interventional treatment of neuroendocrine liver metastases Surgeon 6 2008 232 239
58. T. Steinmüller, R. Kianmanesh, M. Falconi, A. Scarpa, B. Taal, and D.J. Kwekkeboom Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary Neuroendocrinology 87 2008 47 62
59. M. Pavel, E. Baudin, A. Couvelard, E. Krenning, K. Öberg, and T. Steinmüller ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of the foregut, midgut, hindgut, and unknown primary Neuroendocrinology 95 2012 157 176
60. L.K. Kvols, K.K. Turaga, J. Strosberg, and J. Choi Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver J Natl Compr Canc Netw 7 2009 765 772
61. F.G. Que, D.M. Nagorney, K.P. Batts, L.J. Linz, and L.K. Kvols Hepatic resection for metastatic neuroendocrine carcinomas Am J Surg 169 1995 36 42
62. J.M. Sarmiento, G. Heywood, J. Rubin, D.M. Ilstrup, D.M. Nagorney, and F.G. Que Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival J Am Coll Surg 197 2003 29 37
63. H.Y. Akyildiz, J. Mitchell, M. Milas, A. Siperstein, and E. Berber Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: long-term follow-up Surgery 148 2010 1288 1293
64. S. Evard, Y. Becouarn, M. Fonck, R. Brunet, S. Mathoulin-Pelissier, and V. Picot Surgical treatment of liver metastases by radiofrequency ablation, resection, or in combination Eur J Surg Oncol 30 2004 399 406
65. F. Maire, C. Lombard-Bohas, D. O'Toole, M.-P. Vullierme, V. Rebours, and A. Couvelard Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study Neuroendocrinology 96 2012 294 300
66. S. Gupta, M.M. Johnson, R. Murthy, K. Ahrar, M.J. Wallace, and D.C. Madoff Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival Cancer 104 2005 Oct 15 1590 1602
67. S.K. Gaur, J.L. Friese, C.A. Sadow, R. Ayyagari, C.A. Binkert, and M.P. Schenker Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver Cardiovasc Intervent Radiol 34 2011 566 572
68. J.R. Strosberg, J.M. Weber, J. Choi, T.L. Campos, T.L. Valone, and G. Han A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors Ann Oncol 23 2012 2335 2341
69. Y.P. Le Treut, E. Grégoire, J. Belghiti, O. Boillot, O. Soubrane, and G. Mantion Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report Am J Transplant 8 2008 1205 1213